JTT-251
/ Japan Tobacco
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 03, 2019
RELIEF-PAH: Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension
(clinicaltrials.gov)
- P2; N=0; Withdrawn; Sponsor: Akros Pharma Inc.; N=160 ➔ 0; Not yet recruiting ➔ Withdrawn
Clinical • Enrollment change • Trial withdrawal
1 to 1
Of
1
Go to page
1